Spots Global Cancer Trial Database for cd19+ b cell malignancies
Every month we try and update this database with for cd19+ b cell malignancies cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study to Compare the Efficacy and Safety of Lisocabtagene Maraleucel vs Investigator's Choice Options in Adult Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Whose Disease Has Failed Treatment With Both BTKi and BCL2i Therapies | NCT06205290 | Leukemia, Lymph... | Liso-cel Idelalisib Rituximab Bendamustine Fludarabine Cyclophosphamid... | 18 Years - | Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | |
| A Study to Compare the Efficacy and Safety of Lisocabtagene Maraleucel vs Investigator's Choice Options in Adult Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Whose Disease Has Failed Treatment With Both BTKi and BCL2i Therapies | NCT06205290 | Leukemia, Lymph... | Liso-cel Idelalisib Rituximab Bendamustine Fludarabine Cyclophosphamid... | 18 Years - | Juno Therapeutics, Inc., a Bristol-Myers Squibb Company |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
